Ignite Creation Date:
2024-05-06 @ 7:40 PM
Last Modification Date:
2024-10-26 @ 3:11 PM
Study NCT ID:
NCT06094296
Status:
COMPLETED
Last Update Posted:
2024-06-25
First Post:
2023-10-17
Brief Title:
A Study of BMS-986315 and Nivolumab in Combination With Chemotherapy in Participants With First-line Stage IV or Recurrent Non-small Cell Lung Cancer NSCLC
Sponsor:
Bristol-Myers Squibb
Organization:
Bristol-Myers Squibb
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-11-27
Start Date Type:
ACTUAL
Primary Completion Date:
2026-10-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-10-27
Completion Date Type:
ESTIMATED
First Submit Date:
2023-10-17
First Submit QC Date:
October 17 2023
Study First Post Date:
2023-10-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-10
Last Update Post Date:
2024-06-25
Last Update Post Date Type:
ACTUAL